Objectives: This study aimed to analyze the impact of replacing heparin with bivalirudin in
octogenarians undergoing percutaneous coronary intervention (PCI) on postprocedure …

Purpose The aim of this study was to explore the safety and efficacy of bivalirudin in elderly
patients undergoing percutaneous coronary intervention (PCI). Methods An electronic …

Objective To assess the effectiveness and safety of bivalirudin compared with heparin
monotherapy in elderly patients undergoing percutaneous coronary intervention (PCI) …

Background: With an aging population, nonagenarians constitute an increasing percentage
of patients with coronary artery disease. The aim of this study was to determine the …

Bivalirudin as an anticoagulant reduces bleeding after percutaneous coronary intervention
(PCI), while its impact in elderly Chinese patients treated with PCI needs more evidence …

Compared to unfractionated heparin (UFH), bivalirudin decreases bleeding during
percutaneous coronary interventions (PCIs). We sought to investigate the association …

Aims To evaluate the effectiveness and safety of bivalirudin as used in routine care.
Bivalirudin has been studied as an alternative to heparin plus glycoprotein IIb/IIIa inhibitor …

Objective ST-segment elevation myocardial infarction (STEMI) is the most serious type of
acute coronary syndrome. This study aimed to investigate the efficacy and safety of …

Objectives We aimed to perform a gender‐based meta‐analysis of the outcome of
bivalirudin versus heparin in patients undergoing percutaneous coronary interventions …

Background Since older age is a strong predictor of not only bleeding but also of ischemic
events, understanding the risk: benefit profile of bivalirudin in the elderly undergoing primary …